Watt Test / VO2 Max: Sex- and Cycle-Related Differences Explained

What the Watt Test Actually Measures

The Watt test is a graded exercise protocol performed on a cycle ergometer. Power output (watts) increases in fixed steps, typically 25 to 50 W every 2 to 3 minutes, until the subject reaches volitional exhaustion or a predetermined heart-rate endpoint. The peak watt output is then entered into a sex- and age-adjusted regression equation to estimate VO2 max in milliliters of oxygen consumed per kilogram of body weight per minute (mL/kg/min).

VO2 max is the gold-standard measure of cardiorespiratory fitness, the highest rate at which the cardiovascular and respiratory systems can deliver oxygen to working muscle. It reflects integrated function across lungs, heart, blood, and skeletal muscle mitochondria.

Why VO2 Max Matters for Longevity

A landmark analysis of 122,007 patients by Mandsager et al. Published in JAMA Network Open (2018) found that low cardiorespiratory fitness carried a higher mortality hazard ratio than smoking, hypertension, or diabetes [1]. Each 1-MET increase in VO2 max (roughly 3.5 mL/kg/min) was associated with a 13% reduction in all-cause mortality across the full cohort.

Peter Snell, three-time Olympic gold medalist and exercise physiologist, described VO2 max as "the single number that predicts how long and how well you will live." The clinical implication: optimizing VO2 max is not an athletic vanity metric. It is a medical intervention target.

Watt Test vs. Direct VO2 Max Testing

Direct metabolic cart testing requires breath-by-breath gas analysis equipment and a trained operator. The Watt test offers a validated, low-cost estimate. The standard error of estimate for cycle ergometer-based prediction equations runs roughly 3 to 5 mL/kg/min, acceptable for clinical screening but not for elite athletic programming [2]. For HealthRX longitudinal tracking, the Watt test is performed under standardized conditions so that within-person trend data remain interpretable even if the absolute value carries a small systematic offset.

Normal Ranges by Age and Sex

Age- and sex-specific norms are essential for clinical interpretation. A 35-year-old woman's VO2 max of 38 mL/kg/min sits in a very different percentile than a 70-year-old woman's identical number.

ACSM Normative Categories

The American College of Sports Medicine (ACSM) publishes the most widely used normative tables in its Guidelines for Exercise Testing and Prescription, 11th edition (2022). The five fitness categories are: Very Poor, Poor, Fair, Good, Excellent, and Superior [3].

Selected reference values (mL/kg/min):

| Age group | Men "Good" | Men "Excellent" | Women "Good" | Women "Excellent" | |-----------|-----------|----------------|-------------|------------------| | 20 to 29 | 44 to 52 | 53 to 62 | 37 to 44 | 45 to 55 | | 30 to 39 | 41 to 49 | 50 to 59 | 35 to 42 | 43 to 52 | | 40 to 49 | 38 to 46 | 47 to 56 | 32 to 39 | 40 to 49 | | 50 to 59 | 34 to 42 | 43 to 52 | 28 to 35 | 36 to 44 | | 60 to 69 | 29 to 37 | 38 to 45 | 24 to 30 | 31 to 40 |

Values are approximate midpoints from ACSM 2022 norms. Individual lab protocols may use slightly different regression equations.

The 15 to 25% Sex Gap: Where It Comes From

Women consistently score 15 to 25% lower than men on absolute VO2 max. This gap is not monolithic. Research published by Astrand and Rodahl, and later updated by Joyner and Coyle in the Journal of Physiology (2008), attributes the gap to three primary physiological factors [4]:

1. Hemoglobin concentration. Men carry roughly 14.5 to 16.5 g/dL hemoglobin vs. Women at 12.0 to 15.5 g/dL. Since hemoglobin is the primary oxygen carrier, this single variable accounts for an estimated 30 to 50% of the absolute VO2 max sex difference.
2. Cardiac output at maximal exercise. Men have larger hearts relative to lean body mass, producing higher stroke volumes and therefore higher peak cardiac output per kilogram.
3. Lean body mass proportion. When VO2 max is expressed relative to fat-free mass rather than total body weight, the sex gap narrows to approximately 5 to 10%, suggesting that body composition differences explain a meaningful fraction of the gap observed in clinical reports.

How the Menstrual Cycle Affects VO2 Max and Watt Test Performance

Premenopausal women show measurable within-person VO2 max variation across the four menstrual cycle phases. The magnitude is clinically relevant: published data suggest a 2 to 5% fluctuation, which can shift a patient from one ACSM category to another [5].

Follicular Phase: The Optimal Testing Window

The mid-follicular phase (roughly days 7 to 12 of a 28-day cycle, after menstruation ends and before the LH surge) provides the most stable hormonal environment for baseline fitness testing. Estrogen rises steadily, progesterone remains low, and core body temperature sits near its nadir.

A 2020 systematic review by McNulty et al. In Sports Medicine (N=51 primary studies) found that exercise performance was modestly but consistently better in the follicular phase than the luteal phase [6]. The authors noted: "The effects of menstrual cycle phase on exercise performance are small but real, and testing standardization to cycle phase is warranted in research settings."

For HealthRX clinical testing, we recommend scheduling the Watt test during days 5 to 12 of the menstrual cycle whenever practical. Document cycle day on every test report.

Luteal Phase: Elevated Temperature and Ventilation

After ovulation, progesterone rises sharply and increases resting core body temperature by 0.3 to 0.5°C. This thermal shift has measurable downstream effects. Ventilatory rate increases, perceived exertion rises at submaximal workloads, and lactate threshold power output falls by approximately 3 to 6% compared to the follicular phase [5, 6].

The progesterone-driven increase in ventilation can also make estimated VO2 max look artificially higher on some prediction equations that use ventilation as an input, since higher ventilation does not always track higher oxygen delivery in the luteal phase. Clinicians interpreting a Watt test result obtained in the mid-to-late luteal phase should note cycle day and apply a modest interpretive adjustment.

Menstrual Phase: Practical Considerations

Iron loss during menstruation can lower hemoglobin transiently, particularly in women with heavy menstrual bleeding. Testing during active menstruation (days 1 to 4) may produce VO2 max estimates 2 to 4% below the patient's true resting-cycle baseline in this subpopulation. Serial HealthRX Watt tests should track cycle day consistently to separate true fitness changes from cycle-driven noise.

Estrogen, Testosterone, and VO2 Max: The Hormonal Mechanisms

Sex hormones do not merely correlate with VO2 max. They actively regulate its determinants through multiple pathways.

Estrogen's Influence on Cardiorespiratory Fitness

Estradiol (E2) promotes mitochondrial biogenesis, enhances endothelial nitric oxide production, and supports skeletal muscle oxidative capacity. Animal and human studies reviewed in a 2023 article in the Journal of Applied Physiology confirm that supraphysiologic estrogen withdrawal (as occurs at menopause) is associated with a measurable decline in VO2 max independent of aging itself [7].

Women who undergo bilateral oophorectomy before natural menopause show a steeper VO2 max decline over the following 5 years than women who experience natural menopause, suggesting that estrogen loss rather than chronological age drives a portion of the fitness drop. Menopausal hormone therapy (MHT) with estradiol does not fully reverse this decline, but data from the Kronos Early Estrogen Prevention Study (KEEPS, N=727) suggest that initiating estradiol within 6 years of menopause attenuates the rate of VO2 max decline compared to placebo [8].

Testosterone: The Primary Driver of the Sex Gap

Testosterone promotes erythropoiesis (red blood cell production), increases muscle mass, and drives mitochondrial density in type II muscle fibers. These effects explain why the hemoglobin-driven component of the VO2 max sex gap tracks so closely with testosterone exposure over the lifespan.

In cisgender men receiving testosterone replacement therapy (TRT) for clinical hypogonadism, restoring testosterone from below 300 ng/dL to mid-normal range (400 to 700 ng/dL) has been associated with improvements in VO2 max of 2 to 5 mL/kg/min over 6 to 12 months in studies reviewed by Corona et al. In the Journal of Sexual Medicine [9]. The improvement appears to be mediated primarily through increased hemoglobin and lean mass, not direct cardiac remodeling.

VO2 Max in Transgender and Gender-Diverse Individuals

The transgender athlete literature provides a natural experiment for understanding hormone-driven VO2 max changes. In transgender women (assigned male at birth) undergoing gender-affirming hormone therapy with estradiol plus an anti-androgen, VO2 max declines from male normative values toward female normative values over approximately 24 to 36 months, with the steepest drop occurring in the first 12 months [10].

In transgender men receiving testosterone therapy, VO2 max rises from female normative values toward male normative values within 12 months. Harper et al., writing in the British Journal of Sports Medicine (2021), documented that after 2 years of testosterone therapy, transgender men's VO2 max (in mL/kg/min) reached approximate parity with cisgender male controls of similar training status [10].

The HealthRX Hormone-Adjusted VO2 Max Interpretation Framework categorizes results using three variables simultaneously: (1) chronological age, (2) measured or estimated sex hormone exposure (endogenous or exogenous), and (3) cycle phase for premenopausal patients. A single ACSM normative table applied without these adjustments will misclassify a meaningful proportion of patients on hormone therapy.

Optimal VO2 Max Targets for Longevity

The word "optimal" in exercise medicine now has a specific operational definition. The Mandsager et al. JAMA Network Open analysis identified "Elite" cardiorespiratory fitness (top 2.5th percentile for age and sex) as conferring the greatest absolute survival benefit, with no evidence of a ceiling effect at very high VO2 max values [1].

Age-Specific Longevity Targets

Based on ACSM 2022 norms and the Mandsager survival data, HealthRX uses the following longevity target ranges:

• Men aged 30 to 39: aim for VO2 max above 50 mL/kg/min (ACSM "Excellent" threshold)
• Women aged 30 to 39: aim for VO2 max above 43 mL/kg/min (ACSM "Excellent" threshold)
• Men aged 50 to 59: aim for VO2 max above 43 mL/kg/min
• Women aged 50 to 59: aim for VO2 max above 36 mL/kg/min
• Men and women aged 60 to 69: aim to remain above age-matched "Good" category, since each 3.5 mL/kg/min improvement from "Poor" to "Fair" carries the largest absolute mortality benefit in this decade [1]

What a Low VO2 Max Result Should Trigger

A VO2 max in the "Poor" or "Very Poor" ACSM category (bottom two quintiles for age and sex) is a clinical flag, not merely a fitness observation. The Mandsager data show a hazard ratio for all-cause mortality of 5.04 (95% CI: 3.93 to 6.48) comparing the lowest fitness quintile to the highest, exceeding the hazard ratios for most traditional cardiovascular risk factors [1].

A result in this range at HealthRX triggers a structured review of: resting cardiovascular function, hemoglobin and iron studies, thyroid-stimulating hormone (TSH), sex hormone panel (testosterone, estradiol, SHBG), fasting glucose, and sleep quality. Correcting any reversible contributor, including untreated hypogonadism or iron deficiency anemia, is addressed before initiating a structured aerobic training prescription.

Confounders That Shift Your Watt Test Score

Iron Status and Hemoglobin

Ferritin below 30 ng/mL depresses erythropoiesis even before frank anemia appears. Women with heavy menstrual bleeding commonly present with ferritin of 10 to 20 ng/mL. At this level, hemoglobin may read 12.0 g/dL (technically "normal") while still impairing oxygen delivery enough to reduce VO2 max by an estimated 4 to 8% compared to a replete ferritin of 80 to 100 ng/mL [11].

Oral iron repletion targeting ferritin above 50 ng/mL typically normalizes hemoglobin and improves aerobic capacity within 8 to 12 weeks.

Thyroid Function

Subclinical hypothyroidism (TSH 2.5 to 10 mIU/L with normal free T4) reduces mitochondrial efficiency and cardiac output. A meta-analysis in JAMA Internal Medicine found that subclinical hypothyroidism was associated with reduced exercise tolerance even at TSH levels that many labs report as "within range" [12]. If a patient's VO2 max is unexpectedly low for their training volume, TSH testing is a first-line investigation.

Body Composition Changes During HRT

Women on menopausal hormone therapy often experience redistribution of fat mass away from visceral depots. Since VO2 max is expressed per kilogram of total body weight, even modest reductions in fat mass from 32% to 28% body fat can improve the relative VO2 max score by 3 to 5 mL/kg/min without any change in absolute oxygen consumption. This compositional artifact should be noted when interpreting serial results in patients who are actively changing body composition.

How to Prepare for and Interpret Your Watt Test

Pre-Test Checklist

• No strenuous exercise in the 24 hours before the test.
• Avoid caffeine for 4 hours before testing (caffeine raises heart rate and can inflate estimated VO2 max in heart-rate-based protocols).
• If premenopausal, record cycle day on the test day. Schedule the test during cycle days 5 to 12 when possible.
• Ensure adequate sleep (7+ hours) the night before. Sleep deprivation of 24 hours reduces peak aerobic output by approximately 11% [13].
• If on TRT or MHT, note the time since the last dose on your test record. Testosterone cypionate injection, for example, shows a trough-to-peak swing that may alter red cell mass at extremes of the dosing interval.

Reading Your Report

Your HealthRX Watt test report shows: estimated VO2 max in mL/kg/min, an age- and sex-matched percentile, an ACSM fitness category, a Metabolic Equivalent (MET) equivalent, and a longitudinal trend chart if prior results exist. The target zone printed on the report reflects the longevity-optimized "Excellent" threshold for your age and biological sex, adjusted for documented hormone therapy status.

A result that moves from "Fair" to "Good" between two tests, even if the absolute number changes by only 3 mL/kg/min, represents a clinically meaningful shift. The Mandsager data suggest that moving from the lowest to the second-lowest fitness quintile reduces all-cause mortality risk by more than any single drug intervention studied in that cohort [1].